Cargando…

Strategies for the introduction of human papillomavirus vaccination: modelling the optimum age- and sex-specific pattern of vaccination in Finland

Phase III trials have demonstrated the efficacy of human papillomavirus (HPV) vaccines in preventing transient and persistent high-risk (hr) HPV infection and precancerous lesions. A mathematical model of HPV type 16 infection and progression to cervical cancer, parameterised to represent the infect...

Descripción completa

Detalles Bibliográficos
Autores principales:	French, K M, Barnabas, R V, Lehtinen, M, Kontula, O, Pukkala, E, Dillner, J, Garnett, G P
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2007
Materias:	Epidemiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360033/ https://www.ncbi.nlm.nih.gov/pubmed/17245341 http://dx.doi.org/10.1038/sj.bjc.6603575

Ejemplares similares

Epidemiology of HPV 16 and Cervical Cancer in Finland and the Potential Impact of Vaccination: Mathematical Modelling Analyses
por: Barnabas, Ruanne V, et al.
Publicado: (2006)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
por: Bjørge, T, et al.
Publicado: (2002)

Type- and age-specific distribution of human papillomavirus in women attending cervical cancer screening in Finland
por: Leinonen, M K, et al.
Publicado: (2013)

Human papillomavirus vaccine efficacy against invasive, HPV-positive cancers: population-based follow-up of a cluster-randomised trial
por: Lehtinen, Matti, et al.
Publicado: (2021)

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
por: Lehtinen, Matti, et al.
Publicado: (2021)

A population-based study on the risk of cervical cancer and cervical intraepithelial neoplasia among grand multiparous women in Finland
por: Hinkula, M, et al.
Publicado: (2004)

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Education, survival and avoidable deaths in cancer patients in Finland
por: Pokhrel, A, et al.
Publicado: (2010)

Human papillomavirus DNA in men who have sex with men: type-specific prevalence, risk factors and implications for vaccination strategies
por: King, E M, et al.
Publicado: (2015)

Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953–2010
por: Luoto, R, et al.
Publicado: (2004)

Geospatial patterns of human papillomavirus vaccine uptake in Minnesota
por: Nelson, Erik J, et al.
Publicado: (2015)

Health service utilisation for anogenital warts in Ontario, Canada prior to the human papillomavirus (HPV) vaccine programme introduction: a retrospective longitudinal population-based study
por: Guerra, Fiona M, et al.
Publicado: (2016)

Human papillomavirus seroprevalence in pregnant women following gender-neutral and girls-only vaccination programs in Finland: A cross-sectional cohort analysis following a cluster randomized trial
por: Gray, Penelope, et al.
Publicado: (2021)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Estimating the long-term impact of a prophylactic human papillomavirus 16/18 vaccine on the burden of cervical cancer in the UK
por: Kohli, M, et al.
Publicado: (2007)

Anogenital Human Papillomavirus and HIV Infection in Rwandan Men Who Have Sex With Men
por: Murenzi, Gad, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Piloting gender-oriented colorectal cancer screening with a faecal immunochemical test: population-based registry study from Finland
por: Sarkeala, Tytti, et al.
Publicado: (2021)

Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study
por: Bjørge, T, et al.
Publicado: (2004)

Impacts of human papillomavirus vaccination for different populations: A modeling study
por: Baussano, Iacopo, et al.
Publicado: (2018)

Joint Nordic prospective study on human herpesvirus 8 and multiple myeloma risk
por: Tedeschi, R, et al.
Publicado: (2005)

Human papillomavirus (HPV) vaccination and oropharyngeal HPV in ethnically diverse, sexually active adolescents: community-based cross-sectional study
por: Kerry-Barnard, Sarah, et al.
Publicado: (2021)

Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis
por: Fortanier, Alexandre C, et al.
Publicado: (2018)

Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance
por: King, Eleanor M, et al.
Publicado: (2015)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Estimating the direct effect of human papillomavirus vaccination on the lifetime risk of screen‐detected cervical precancer
por: Inturrisi, Federica, et al.
Publicado: (2020)

Introduction to Optimum Design
por: Arora, Jasbir
Publicado: (2004)

Effectiveness of screening for colorectal cancer with a faecal occult-blood test, in Finland
por: Pitkäniemi, J, et al.
Publicado: (2015)

Human Papillomavirus Vaccination Strategies
por: Cachafeiro, Santiago Pérez
Publicado: (2007)

Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia
por: Lehtinen, Matti, et al.
Publicado: (2011)

Incidence trends of vestibular schwannomas in Denmark, Finland, Norway and Sweden in 1987–2007
por: Larjavaara, S, et al.
Publicado: (2011)

Evaluation of vaccination strategies for the metropolitan area of Madrid via agent-based simulation
por: Singh, David E, et al.
Publicado: (2022)

Modelling an optimum vaccination strategy against ZIKA virus for outbreak use
por: Massad, Eduardo, et al.
Publicado: (2019)

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
por: Kavanagh, K, et al.
Publicado: (2014)

Moral dilemma(s) in human papillomavirus vaccination – revisiting the role of the herd effect
por: Lehtinen, Matti, et al.
Publicado: (2021)

Global Distribution of Invasive Serotype 35D Streptococcus pneumoniae Isolates following Introduction of 13-Valent Pneumococcal Conjugate Vaccine
por: Lo, Stephanie W., et al.
Publicado: (2018)

Ten-year follow-up of human papillomavirus vaccine efficacy against the most stringent cervical neoplasia end-point—registry-based follow-up of three cohorts from randomized trials
por: Lehtinen, Matti, et al.
Publicado: (2017)

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial
por: Ramanakumar, Agnihotram V, et al.
Publicado: (2016)

Cancer incidence among Finnish ferrochromium and stainless steel production workers in 1967–2011: a cohort study
por: Huvinen, Markku, et al.
Publicado: (2013)

Changes in objectively measured smoking in pregnancy by time and legislative changes in Finland: a retrospective cohort study
por: Männistö, T, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_674fvb3u03u5b1pcdafnifi5uq